Trastuzumab vs Trastuzumab Deruxtecan

## Trastuzumab vs Trastuzumab Deruxtecan: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Trastuzumab Deruxtecan**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Trastuzumab Deruxtecan — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Trastuzumab Deruxtecan — Antibody drug conjugate.